Market Overview - A-shares indices collectively rose, with the Shanghai Composite Index reaching a new closing high for the year, up by 0.45% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.7341 trillion yuan, an increase of 138 billion yuan from the previous day [1] Sector Performance - The Robotics 50 ETF (159559) led the market gains, with the Robotics ETF E Fund (159530) rising over 4% [2] - Several military and robotics ETFs also saw gains exceeding 3% [2] - The Shanghai Municipal Government released a plan to develop the embodied intelligence industry, aiming for breakthroughs in at least 20 core algorithms and technologies by 2027, with a target industry scale exceeding 50 billion yuan [2] Investment Insights - Oriental Securities noted that AI investments and applications will accelerate the development of the robotics sector, with hardware companies likely to benefit from rapid advancements in AI [3] - The recent implementation of national collection results for traditional Chinese medicine in various provinces is expected to drive technological upgrades in the industry, favoring companies with comprehensive advantages and innovative capabilities [4] ETF Market Activity - The ETF market showed signs of cooling, with notable declines in traditional Chinese medicine-related ETFs [5] - The 5-Year Local Government Bond ETF (511060) had the highest turnover rate at 168.83% [6][7] - The Short-term Bond ETF (511360) led in trading volume, reaching 20 billion yuan [6] Upcoming Developments - New ETFs in the Hong Kong stock market related to the medical sector are set to launch, with a focus on the upcoming innovation drug industry conference [8] - The innovation drug sector is expected to maintain its growth trajectory, supported by policies and improving fundamentals [8]

Core Viewpoint - The Hong Kong Stock Connect Medical ETF (trading code: 520510) is set to be listed on the Shanghai Stock Exchange on August 7, 2025, providing investors with a convenient tool to access the Hong Kong medical sector [1] Group 1: ETF Details - The ETF supports T+0 trading, filling a gap in the Hong Kong Stock Connect medical sector [1] - It tracks the Hong Kong Stock Connect Medical Theme Index (932069.CSI), which covers three major sub-sectors within the medical industry [1] Group 2: Index Composition - The ETF has over 30% weight in CXO holdings, leading among all market indices [1] - AI medical holdings account for over 20%, positioning the ETF to benefit from trends such as anti-involution, innovative drug exports, and the AI technology revolution [1]

Group 1 - The Hong Kong medical sector has experienced explosive growth since 2025, driven by policy changes and market dynamics, with the Hang Seng Healthcare Index rising by 50.09% year-to-date, outperforming both A-share pharmaceutical indices and the CSI 300 [1] - The China Securities Index for Hong Kong Medical Theme has reached a market capitalization of 2.21 trillion, significantly expanding its representation and surpassing 35% of the total market capitalization of A-share pharmaceutical companies [2] - The index focuses on two core areas: research and services, covering nearly 99% of the pharmaceutical industry chain, with significant weight in biotechnology and medical devices [2] Group 2 - The index includes major industry leaders, with a balanced weight distribution towards biotechnology and pharmaceutical retail, indicating potential for further concentration on core pharmaceutical enterprises [2] - Earnings expectations for the index constituents are projected to grow at double-digit rates, with net profit growth rates of 18.68% and 17.11% for 2025 and 2026, respectively, while the current P/E ratio of 26 indicates a historical low [2] - The launch of the Hong Kong Medical ETF (520510) by Huaxia Fund aims to provide investors with a convenient tool to access the growth opportunities in the Hong Kong medical sector [4]